Accenture plc

ACN · CIK 0001467373

18 fiscal years · 68 SEC filings · every number carries its receipt

Revenue (FY)

$69.67B7.4%

FY2025

Net income (FY)

$7.68B5.7%

FY2025

Free cash flow (FY)

$10.87B26.2%

FY2025

Diluted EPS (FY)

$12.156.2%

FY2025

The story, charted

The shape of the business

FY2008–FY2025 · hover any year for its receipt

Revenue & net incomeRevenueNet income

revenue 2.8× since FY2008 · net margin 6.7% → 11.0%

MarginsNet marginFCF margin

FY2025: net 11.0% · free cash flow 15.6% of revenue

Cash engineOperating cash flowFree cash flow

FY2025: $11.47B operating cash − $600.0M capex = $10.87B free cash flow

Returns on capitalReturn on equityReturn on assets

return on equity 56% (FY2009) → 25% (FY2025) · on assets 11.7%

The receipts

Financial statements

Annual Quarterly (as reported)

USD in millions except per-share and share counts. Every value links to the filing it came from — hover for the us-gaap tag, click for the 10-K/10-Q on sec.gov.

USD millions	Q3 2026	Q2 2026	Q1 2026	Q3 2025	Q2 2025	Q1 2025	Q3 2024	Q2 2024	Q1 2024	Q3 2023	Q2 2023	Q1 2023
Revenue	18,718	18,044	18,742	17,728	16,659	17,690	16,467	15,800	16,224	16,565	15,814	15,748
Net income	2,339	1,825	2,212	2,198	1,788	2,279	1,932	1,675	1,973	2,010	1,524	1,965
Diluted EPS	3.80	2.93	3.54	3.49	2.82	3.59	3.04	2.63	3.10	3.15	2.39	3.08
Diluted shares	616	623	626	630	634	635	636	637	637	639	638	639
Operating cash flow	—	—	1,664	—	—	1,022	—	—	499	—	—	495
Capital expenditures	—	—	157	—	—	152	—	—	69	—	—	99
Free cash flow	—	—	1,508	—	—	870	—	—	430	—	—	397
Cash & equivalents	10,165	9,399	9,649	9,632	8,490	8,306	5,537	5,121	7,141	8,535	6,239	5,900
Total assets	68,807	67,064	64,698	63,362	59,870	59,868	54,141	51,307	51,531	50,128	47,727	47,116
Shareholders' equity	31,891	31,211	30,868	30,555	29,246	29,190	27,744	27,123	26,677	25,332	23,763	22,975

Figures as reported in SEC filings, normalized by stonks with the tag mapping shown on hover; missing tags render as “—”, never as zero. Free cash flow is derived (operating cash flow − capex) with both parents recorded in its lineage. Quarterly view shows as-reported 10-Q periods; Q4 synthesis ships in Phase 1. See methodology.